White Papers
-
A Strategic Guide For Biotech And Biopharma Leaders
5/15/2025
Securing drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.
-
Infectious Diseases - Global Clinical Trial Landscape (2025)
5/14/2025
The global infectious disease clinical trial landscape has rapidly expanded between 2020 and 2024, driven by the urgency of emerging threats, technological innovation, and evolving regulatory frameworks.
-
Obesity - Global Clinical Trial Landscape (2025)
5/14/2025
This report analyzes the current state of global and Asia-Pacific obesity trials, highlighting regional trends, sponsor activity, and preferred endpoints.
-
How Early-Stage Planning Strategies Are Optimizing Drug Development
5/12/2025
Early integration of a target product profile (TPP) into early-stage planning is pivotal for steering drug development toward both regulatory success and commercial impact.
-
Small Cell Lung Cancer- Global Clinical Trial Landscape (2025)
5/9/2025
Historically dominated by chemotherapy and radiation, the treatment paradigm for small cell lung cancer (SCLC) is evolving in response to limited survival benefits and high relapse rates.
-
Breaking Through Barriers With Integrated Trial Optimization
5/9/2025
In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.
-
What Clinical Trial Decision Makers Are Prioritizing In 2025
5/7/2025
In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.
-
American Academy Of Ophthalmology IRIS Registry Report
5/1/2025
The 2024 IRIS® Registry Industry Report showcases the transformative power of real-world data (RWD) in ophthalmology.
-
A 2025 Survey Report Uncovers The Top 5 Clinical Trial Cost Insights
4/22/2025
In this 2025 survey of over 100 U.S. clinical trial participants and caregivers, we reveal that most individuals join trials seeking life-saving treatment, not financial gain.
-
Patient-Reported Outcome In Oncology Clinical Trials
4/17/2025
As cancer therapies grow more complex and personalized, patient-reported outcomes (PROs) have emerged as a vital component of oncology research and care.